If you are looking for strategic partners like MicroPort®, please contact BD@microport.com for further discussion.
During the last 25+ years, MicroPort® has established a series of professional service platforms (some pictured in the figure below) to accelerate new product launches. Through the Incubator PLUS program at Miracle Point®, external companies can access these platforms and additional resources to accelerate development in a capital-efficient manner. Thus far, Miracle Point® has incubated 30+ portfolio companies globally in fields that include neuromodulation, robotics, sports medicine, aesthetic treatments, assisted reproduction, ophthalmology, wearable devices, and rehabilitation devices.
In addition to providing physical space and professional services to the portfolio companies at different stages, MicroPort® has established partnerships with more than 30 external venture funds, including but not limited to: CITIC, China Renaissance, CICC, Huaitai Securities, Hillhouse, Lake Bleu, and GlC.
Through close yet flexible collaboration, Miracle Point® aims to help entrepreneur's dreams come true to further the MicroPort® mission of pushing boundaries so that patients everywhere can enjoy better and longer lives.
MicroPort® welcomes global entrepreneurs in the medical technology field to join us at Miracle Point®. Please contact us at MiraclePoint@microport.com for further information.
In order to understand the patient's medical needs in a more detailed way, and to better understand the pain points, MicroPort® has built a platform for collecting medical insights in the Collaborative Creative Center to facilitate communication between MicroPort® and patients, doctors, and innovatively develop products that truly belong to patients and doctors.
As early as 2002, MicroPort® foresaw that doctors are the important Power for innovation transformation. Through close cooperation of medical workers, we can continuously develop innovative projects for the development of medical devices. Since the founding of MicroPort®, 48 medical cooperation projects have been developed, 9 of which have obtained CFDA certificates, and 8 of which have completed sample evaluation.
We are actively strengthening cooperation with the global medical industry to 'help people thrive beyond 115 years'. We hope to achieve a win-win situation after this close cooperation and to develop more useful products.